+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
Healthy Volunteers
ID06684197

Evaluating Dexmedetomidine Infusion to Reduce Opioid Use During Laparoscopic Abdominal Surgery in a Randomized Controlled Trial

Led by Ciusss de L'Est de l'Île de Montréal · Updated on 2026-10-23

72

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the effects of dexmedetomidine, a selective alpha-2 adrenergic receptor agonist, on reducing the need for opioids during laparoscopic abdominal surgery. Opioids, while effective for pain relief during surgery, have significant short- and long-term side effects. This trial aims to see if dexmedetomidine can lower intraoperative remifentanil consumption and improve post-surgery pain and recovery, including in patients with varying health statuses classified as ASA 1 to 3. Participants will be randomly assigned to receive either dexmedetomidine or a placebo normal saline during surgery. The dexmedetomidine is given as a 0.5 mcgkg bolus over 10 minutes during anesthesia induction, followed by a continuous infusion up to a maximum dose or until pneumoperitoneum is deflated. The placebo group receives an equivalent volume of saline. Treatments are delivered via an infusion pump during the surgery. During the study, researchers will monitor remifentanil consumption, blood pressure, heart rate, and other vital signs throughout surgery. Postoperative assessments include pain scores, opioid use in the recovery room, adverse events, time to extubation, and quality of recovery at 24 hours. The trial is designed to last from anesthesia induction to discharge from the post-anesthesia care unit, with follow-up on recovery and pain one day after surgery.

CONDITIONS

Brief Title

The Impact of a Dexmedetomidine Perfusion on Intraoperative Remifentanil Consumption

Research Team

O

Olivier Verdonck

N

Nadia Godin

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here